vs
Digimarc CORP（DMRC）与RYTHM, Inc.（RYM）财务数据对比。点击上方公司名可切换其他公司
RYTHM, Inc.的季度营收约是Digimarc CORP的1.2倍（$10.7M vs $8.9M），Digimarc CORP净利率更高（-47.2% vs -127.6%，领先80.4%），RYTHM, Inc.同比增速更快（242.0% vs 2.9%），过去两年RYTHM, Inc.的营收复合增速更高（102.6% vs -5.3%）
迪吉马克公司是一家企业软件与服务提供商，其主打产品包含带数字标识符的软件，主要用于解决防伪问题、验证产品真伪、提升回收准确性以及实现供应链可追溯，产品可广泛应用于服装、快消品、美妆健康、汽车等多个行业领域。
RYTHM Inc.是一家临床阶段生物制药企业，专注于研发和商业化针对罕见遗传性内分泌与代谢疾病的创新疗法，主要面向美国市场，服务存在未被满足医疗需求的儿童及成人患者群体。
DMRC vs RYM — 直观对比
营收规模更大
RYM
是对方的1.2倍
$8.9M
营收增速更快
RYM
高出239.1%
2.9%
净利率更高
DMRC
高出80.4%
-127.6%
两年增速更快
RYM
近两年复合增速
-5.3%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $8.9M | $10.7M |
| 净利润 | $-4.2M | $-13.6M |
| 毛利率 | 63.5% | 75.5% |
| 营业利润率 | -48.2% | -121.5% |
| 净利率 | -47.2% | -127.6% |
| 营收同比 | 2.9% | 242.0% |
| 净利润同比 | 51.4% | 44.1% |
| 每股收益（稀释后） | $-0.18 | $-6.78 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收DMRCRYM
| Q4 25 | $8.9M | $10.7M | ||
| Q3 25 | $7.6M | $4.0M | ||
| Q2 25 | $8.0M | $2.0M | ||
| Q1 25 | $9.4M | $538.0K | ||
| Q4 24 | $8.7M | $-7.5M | ||
| Q3 24 | $9.4M | $1.9M | ||
| Q2 24 | $10.4M | $3.0M | ||
| Q1 24 | $9.9M | $2.6M |
净利润DMRCRYM
| Q4 25 | $-4.2M | $-13.6M | ||
| Q3 25 | $-8.2M | $-10.7M | ||
| Q2 25 | $-8.2M | $-7.4M | ||
| Q1 25 | $-11.7M | $-1.6M | ||
| Q4 24 | $-8.6M | $-24.4M | ||
| Q3 24 | $-10.8M | $-18.7M | ||
| Q2 24 | $-9.3M | $-3.0M | ||
| Q1 24 | $-10.3M | $4.2M |
毛利率DMRCRYM
| Q4 25 | 63.5% | 75.5% | ||
| Q3 25 | 58.3% | 34.0% | ||
| Q2 25 | 58.8% | 33.4% | ||
| Q1 25 | 65.0% | 16.7% | ||
| Q4 24 | 60.8% | — | ||
| Q3 24 | 62.4% | 11.6% | ||
| Q2 24 | 66.1% | 37.6% | ||
| Q1 24 | 62.5% | 6.4% |
营业利润率DMRCRYM
| Q4 25 | -48.2% | -121.5% | ||
| Q3 25 | -109.7% | -219.8% | ||
| Q2 25 | -105.2% | -332.9% | ||
| Q1 25 | -128.9% | -687.9% | ||
| Q4 24 | -105.1% | — | ||
| Q3 24 | -120.4% | -63.1% | ||
| Q2 24 | -96.2% | -28.5% | ||
| Q1 24 | -109.2% | 13.6% |
净利率DMRCRYM
| Q4 25 | -47.2% | -127.6% | ||
| Q3 25 | -106.9% | -263.8% | ||
| Q2 25 | -102.6% | -360.4% | ||
| Q1 25 | -125.2% | -302.2% | ||
| Q4 24 | -99.9% | 324.4% | ||
| Q3 24 | -113.9% | -964.4% | ||
| Q2 24 | -89.3% | -99.3% | ||
| Q1 24 | -104.0% | 163.0% |
每股收益（稀释后）DMRCRYM
| Q4 25 | $-0.18 | $-6.78 | ||
| Q3 25 | $-0.38 | $-5.33 | ||
| Q2 25 | $-0.38 | $-3.74 | ||
| Q1 25 | $-0.55 | $-0.83 | ||
| Q4 24 | $-0.40 | $-24.26 | ||
| Q3 24 | $-0.50 | $-17.28 | ||
| Q2 24 | $-0.43 | $-3.16 | ||
| Q1 24 | $-0.50 | $3.78 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $12.9M | $32.2M |
| 总债务越低越好 | — | $80.6M |
| 股东权益账面价值 | $40.2M | $13.0M |
| 总资产 | $53.0M | $106.7M |
| 负债/权益比越低杠杆越低 | — | 6.19× |
8季度趋势，按日历期对齐
现金及短期投资DMRCRYM
| Q4 25 | $12.9M | $32.2M | ||
| Q3 25 | $12.6M | — | ||
| Q2 25 | $16.1M | $41.0M | ||
| Q1 25 | $21.6M | $24.4M | ||
| Q4 24 | $28.7M | — | ||
| Q3 24 | $33.7M | $267.0K | ||
| Q2 24 | $41.5M | $57.0K | ||
| Q1 24 | $48.9M | $99.0K |
总债务DMRCRYM
| Q4 25 | — | $80.6M | ||
| Q3 25 | — | $90.6M | ||
| Q2 25 | — | $40.6M | ||
| Q1 25 | — | $10.6M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $6.2M | ||
| Q2 24 | — | $4.6M | ||
| Q1 24 | — | — |
股东权益DMRCRYM
| Q4 25 | $40.2M | $13.0M | ||
| Q3 25 | $41.4M | $11.7M | ||
| Q2 25 | $46.5M | $21.0M | ||
| Q1 25 | $50.0M | $26.8M | ||
| Q4 24 | $61.4M | $28.1M | ||
| Q3 24 | $70.2M | $5.5M | ||
| Q2 24 | $77.2M | $8.5M | ||
| Q1 24 | $84.5M | $-5.5M |
总资产DMRCRYM
| Q4 25 | $53.0M | $106.7M | ||
| Q3 25 | $55.4M | $115.2M | ||
| Q2 25 | $60.7M | $69.5M | ||
| Q1 25 | $66.5M | $45.6M | ||
| Q4 24 | $75.8M | $54.0M | ||
| Q3 24 | $85.0M | $39.0M | ||
| Q2 24 | $93.4M | $39.4M | ||
| Q1 24 | $99.7M | $40.6M |
负债/权益比DMRCRYM
| Q4 25 | — | 6.19× | ||
| Q3 25 | — | 7.73× | ||
| Q2 25 | — | 1.94× | ||
| Q1 25 | — | 0.40× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 1.13× | ||
| Q2 24 | — | 0.54× | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $991.0K | $-3.0M |
| 自由现金流经营现金流 - 资本支出 | $895.0K | — |
| 自由现金流率自由现金流/营收 | 10.0% | — |
| 资本支出强度资本支出/营收 | 1.1% | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-12.3M | — |
8季度趋势，按日历期对齐
经营现金流DMRCRYM
| Q4 25 | $991.0K | $-3.0M | ||
| Q3 25 | $-2.6M | $-5.4M | ||
| Q2 25 | $-4.7M | $-8.4M | ||
| Q1 25 | $-5.5M | $-6.7M | ||
| Q4 24 | $-4.2M | $-5.3M | ||
| Q3 24 | $-7.1M | $-1.4M | ||
| Q2 24 | $-6.8M | $-1.8M | ||
| Q1 24 | $-8.4M | $-3.0M |
自由现金流DMRCRYM
| Q4 25 | $895.0K | — | ||
| Q3 25 | $-2.8M | — | ||
| Q2 25 | $-4.9M | — | ||
| Q1 25 | $-5.5M | — | ||
| Q4 24 | $-4.2M | — | ||
| Q3 24 | $-7.2M | — | ||
| Q2 24 | $-6.9M | $-1.8M | ||
| Q1 24 | $-8.5M | $-3.0M |
自由现金流率DMRCRYM
| Q4 25 | 10.0% | — | ||
| Q3 25 | -36.9% | — | ||
| Q2 25 | -61.0% | — | ||
| Q1 25 | -59.1% | — | ||
| Q4 24 | -49.1% | — | ||
| Q3 24 | -75.7% | — | ||
| Q2 24 | -66.1% | -61.2% | ||
| Q1 24 | -85.8% | -115.1% |
资本支出强度DMRCRYM
| Q4 25 | 1.1% | — | ||
| Q3 25 | 2.9% | — | ||
| Q2 25 | 2.5% | — | ||
| Q1 25 | 0.6% | — | ||
| Q4 24 | 0.2% | — | ||
| Q3 24 | 0.7% | — | ||
| Q2 24 | 0.3% | 0.1% | ||
| Q1 24 | 1.1% | 0.1% |
现金转化率DMRCRYM
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | -0.71× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
DMRC
| Subscription | $5.3M | 60% |
| The Government | $3.6M | 41% |
RYM
| Nonlicensing Revenue | $9.5M | 89% |
| Cultivation Business Discontinued Operations | $1.2M | 11% |
